<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ900426-0120</DOCNO><DOCID>900426-0120.</DOCID><HL>   Immunomedics Inc. Patent</HL><DATE>04/26/90</DATE><SO>WALL STREET JOURNAL (J), PAGE B7</SO><CO>   EUROP IMMU</CO><IN>MEDICAL AND BIOTECHNOLOGY (MTC)</IN><LP>   WARREN, N.J. -- Immunomedics Inc. said the European PatentOffice upheld its monoclonal antibody patent for Europe,where it had been challenged by several pharmaceuticalcompanies.   Immunomedics, which is using monoclonal antibody-basedtechnology in the diagnosis and treatment of cancer, says ithas one product in final clinical trials and expects to filefor approval from the Food and Drug Administration early nextyear.</LP><TEXT>   In national over-the-counter trading yesterday,Immunomedics shares closed at $3.625, up 12.5 cents.</TEXT></DOC>